Is Medtronic Stock Underperforming the S&P 500?

Ireland-based Medtronic plc (MDT) manufactures and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients. Valued at a market cap of almost 111 billion, the company innovates solutions that treat more than 70 health conditions, ranging from Parkinson's to diabetes.

Companies worth $10 billion or more are generally described as “large-cap” stocks, and Medtronic fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size, stability, and influence in the healthcare sector. The company distinguishes itself as one of the biggest medical tech companies in the world, operating in more than 150 countries and employing over 95,000 people.